Status:
COMPLETED
The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-75 years
Brief Summary
This prospective study aims; 1. To assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome 2. To evaluate the inflammatory activation following c...
Detailed Description
AF is the most common arrhythmia in clinical practice, affecting \> 2.3 million people in US. It increases dramatically with age and is seen in as many as 9% of individuals by the age of 80 (1). A maj...
Eligibility Criteria
Inclusion
- Age: 18-75 years
- Patients undergoing catheter ablation of atrial fibrillation
- Able and willing to give written consent
Exclusion
- Reversible causes of AF such as pericarditis and hyperthyroidism
- Associated chronic inflammatory diseases such as chronic gingivitis or peri-odontitis, rheumatoid Arthritis, IBD including Ulcerative Colitis and Crohn's disease, Lupus, Ankylosing Spondylitis, COPD, psoriasis, vasculitis
- Patients taking long-term steroid medication
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT01148914
Start Date
June 1 2010
End Date
April 1 2012
Last Update
June 1 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St.David's Medical Center
Austin, Texas, United States, 78705